Breast cancer
Results
Phase 2/3
This trial compared olaparib and chemotherapy to chemotherapy alone for and breast cancer with a change in the BRCA .
The trial was supported by Cancer Research UK. It was open for people to join between 2016 and 2023. The team published the results in 2024 and 2025.
Recruitment start: 1 June 2016
Recruitment end: 31 May 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jean Abraham
AstraZeneca
Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK
University of Cambridge
Last reviewed: 8 September 2025
CRUK internal database number: 14320
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
